Cellares vs Omniabio

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/cellares/omniabio

Category	Cellares	Omniabio
Listed site	cdmo	cdmo
Summary	Cellares operates a global network of Smart Factories delivering integrated development and manufacturing (IDMO) services for cell therapies, with proprietary Cell Shuttle® and Cell Q™ platforms enabling cGMP-compliant, automated manufacturing and quality control at clinical and commercial scale.	OmniaBio is a cell and gene therapy CDMO specializing in process development, analytical development, and GMP manufacturing for lentiviral vectors, iPSCs, and immune cell-based therapies. The company operates a 120,000 sq ft facility in Hamilton, Ontario, integrating AI, automation, and robotics to deliver scalable manufacturing from preclinical to commercial stages.
Services	Cell Therapy Manufacturing Autologous Cell Therapy Manufacturing Allogeneic Cell Therapy Manufacturing CMC Analytical Development Process Development Quality Control Testing CMC Regulatory Submission Support Technology Transfer	Process Development CMC Analytical Development Cell-Line Development Autologous Cell Therapy Manufacturing Allogeneic Cell Therapy Manufacturing Cell Therapy Manufacturing Lentiviral Vector Manufacturing CMC Regulatory Submission Support
Modalities	Cell Therapy	Cell Therapy Gene Therapy
Indications	Data not yet provided.	Data not yet provided.
Locations	Smart Factory, South San Francisco, CA, United States Smart Factory, Bridgewater, NJ, United States Smart Factory - Europe, Leiden, Netherlands Smart Factory - Asia, Kashiwa, Japan	Headquarters & Manufacturing Facility, Hamilton, Ontario, Canada
Certifications	Data not yet provided.	Data not yet provided.
Reviews	Review summary appears after site-level review signal gate opens.	Review summary appears after site-level review signal gate opens.